From metabolomics to proteomics: understanding the role of dopa decarboxylase in Parkinson’s disease. Scientific commentary on: “Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson’s disease”

Authors

Nourhan Shebl, The American University in Cairo
Mohamed Salama, The American University in Cairo

Author's Department

Institute of Global Health & Human Ecology

Second Author's Department

Institute of Global Health & Human Ecology

Find in your Library

https://doi.org/10.1007/s00401-024-02739-5

All Authors

Nourhan Shebl, Mohamed Salama

Document Type

Letter to the Editor

Publication Title

Acta Neuropathologica

Publication Date

6-1-2024

doi

10.1007/s00401-024-02739-5

Comments

Letter. Record derived from SCOPUS.

Recommended Citation

APA Citation

Shebl, N. & Salama, M. (2024). From metabolomics to proteomics: understanding the role of dopa decarboxylase in Parkinson’s disease. Scientific commentary on: “Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson’s disease”. Acta Neuropathologica, 147(1), 10.1007/s00401-024-02739-5
https://fount.aucegypt.edu/faculty_journal_articles/6271

MLA Citation

Shebl, Nourhan, et al. "From metabolomics to proteomics: understanding the role of dopa decarboxylase in Parkinson’s disease. Scientific commentary on: “Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson’s disease”." Acta Neuropathologica, vol. 147,no. 1, 2024,
https://fount.aucegypt.edu/faculty_journal_articles/6271